Calypte geht heute durch die Decke.... - 500 Beiträge pro Seite
eröffnet am 03.12.01 08:54:10 von
neuester Beitrag 03.12.01 13:30:57 von
neuester Beitrag 03.12.01 13:30:57 von
Beiträge: 4
ID: 515.698
ID: 515.698
Aufrufe heute: 0
Gesamt: 541
Gesamt: 541
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 1557 | |
vor 1 Stunde | 1289 | |
vor 1 Stunde | 1200 | |
vor 1 Stunde | 895 | |
heute 07:24 | 803 | |
heute 08:53 | 601 | |
vor 1 Stunde | 482 | |
vor 1 Stunde | 450 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.041,55 | +0,21 | 151 | |||
2. | 2. | 0,1815 | -2,16 | 57 | |||
3. | 6. | 7,6450 | -8,99 | 36 | |||
4. | 4. | 166,54 | +0,17 | 24 | |||
5. | 44. | 484,00 | +1,04 | 22 | |||
6. | 10. | 36,30 | -0,27 | 20 | |||
7. | 3. | 0,1276 | -2,60 | 18 | |||
8. | 16. | 17,950 | +2,28 | 18 |
Seht Euch mal die NEWS vom Weekend bei caly an....
unter www.nasdaq.com Kürzel Caly
Gruß
trackcrack
unter www.nasdaq.com Kürzel Caly
Gruß
trackcrack
Was ist das denn für eine neue Nachricht?Ich komme z.zT.in keine US-Seite,weil ein Telekomkabel beschädigt wurde.
Diese zum Beispiel....
Leider mußt Du selber übersetzten, da mein Englisch besch... ist.Calypte Announces Extended Expiration Dating for HIV-1 Western Blot Products
ALAMEDA, Calif.--(BW HealthWire)--Nov. 29, 2001--Calypte Biomedical Corporation (OTCBB:CALY) today announced that it secured FDA approval for extended dating of its Cambridge HIV-1 Western Blot products from 12 months to 15 months.
Obtaining extended dating was a critical milestone in the Company`s manufacturing strategy. "This approval coupled with other measures aimed at reducing operational cycle time, plus the remarkable turnaround time from the FDA, will allow Calypte to provide product with longer dating and achieve greater operational efficiencies," said Barbara McAleer, General Manager.
"Extended expiration dating also supports our international strategy to offer products that help with the fight against HIV and AIDS worldwide," said Nancy Katz, President and CEO. "We know that the availability of extended dating has been a desire of many customers and that there are several international markets where our western blot products have not been made available. It is anticipated that this approval will make both the urine and serum western blot products a more attractive option in markets that are characterized by extended distribution channels or by the local lot release requirements of foreign-manufactured product."
In addition, extended dating can help new distributors acquire an appropriate working inventory before they have established a predictable demand for the products, since the likelihood of losses through expiration can be minimized.
Calypte Biomedical Corporation, headquartered in Alameda, Calif., is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte`s tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as one of only two FDA-approved HIV-1 supplemental Western Blot tests available for testing serum samples.
Gruß
Trackcrack
Leider mußt Du selber übersetzten, da mein Englisch besch... ist.Calypte Announces Extended Expiration Dating for HIV-1 Western Blot Products
ALAMEDA, Calif.--(BW HealthWire)--Nov. 29, 2001--Calypte Biomedical Corporation (OTCBB:CALY) today announced that it secured FDA approval for extended dating of its Cambridge HIV-1 Western Blot products from 12 months to 15 months.
Obtaining extended dating was a critical milestone in the Company`s manufacturing strategy. "This approval coupled with other measures aimed at reducing operational cycle time, plus the remarkable turnaround time from the FDA, will allow Calypte to provide product with longer dating and achieve greater operational efficiencies," said Barbara McAleer, General Manager.
"Extended expiration dating also supports our international strategy to offer products that help with the fight against HIV and AIDS worldwide," said Nancy Katz, President and CEO. "We know that the availability of extended dating has been a desire of many customers and that there are several international markets where our western blot products have not been made available. It is anticipated that this approval will make both the urine and serum western blot products a more attractive option in markets that are characterized by extended distribution channels or by the local lot release requirements of foreign-manufactured product."
In addition, extended dating can help new distributors acquire an appropriate working inventory before they have established a predictable demand for the products, since the likelihood of losses through expiration can be minimized.
Calypte Biomedical Corporation, headquartered in Alameda, Calif., is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte`s tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as one of only two FDA-approved HIV-1 supplemental Western Blot tests available for testing serum samples.
Gruß
Trackcrack
Hallo, zusammen!
Schaut mal auf das Datum! Die News sind vom 29.11.01! Also mit Sicherheit kein Grund ausgerechnet heute durch die Decke zu gehen! Außerdem: schlechte Marktaussichten für heute: Größter US-Energieversorger hat am Sonntag Konkurs angemeldet. Da kann der MArkt erst heute drauf reagieren. Also müssen wir mit den Stemmarbeiten an der Decke wohl noch ein wenig warten.
Gruß
biologist
Schaut mal auf das Datum! Die News sind vom 29.11.01! Also mit Sicherheit kein Grund ausgerechnet heute durch die Decke zu gehen! Außerdem: schlechte Marktaussichten für heute: Größter US-Energieversorger hat am Sonntag Konkurs angemeldet. Da kann der MArkt erst heute drauf reagieren. Also müssen wir mit den Stemmarbeiten an der Decke wohl noch ein wenig warten.
Gruß
biologist
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
148 | ||
55 | ||
27 | ||
20 | ||
18 | ||
18 | ||
17 | ||
16 | ||
16 | ||
16 |
Wertpapier | Beiträge | |
---|---|---|
16 | ||
14 | ||
12 | ||
10 | ||
10 | ||
10 | ||
9 | ||
9 | ||
9 | ||
9 |